Combined deficiency of prolyl hydroxylase (PHD) 1 and PHD3 increases mesenchymal stem cell number and regulates the hematopoietic stem cell niche

Steve Stegen; Satish Khurana; Nick van Gastel; Sophie Torrekens; Karen Moermans; Peter Carmeliet; Catherine M. Verfaillie; Geert Carmeliet

Related publications

Preprint2018

Heme oxygenase-1 deficiency affects bone marrow niche and triggers premature exhaustion of hematopoietic stem cells.

Krzysztof Szade, Monika Żukowska, Agata Szade, Witold Nowak, Maciej Cieśla, Karolina Bukowska-Straková, Gunsagar S. Gulati, Neli Kachamakova‐Trojanowska, Anna Kusienicka, Elisa Einwallner, Jacek Kijowski, Szymon Czauderna, Harald Esterbauer, Irving L. Weissman, Jozef Dulak, Alicja Józkowicz

Article2016

Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia

Elke Marsch, Jasper A. F. Demandt, Thomas Theelen, Bibian M. E. Tullemans, Kristiaan Wouters, Mariëtte R. Boon, Theo H. van Dijk, Marion J. Gijbels, Ludwig J. Dubois, Steven J.R. Meex, Massimiliano Mazzone, Gene Hung, Edward A. Fisher, Erik A.L. Biessen, Mat J.A.P. Daemen, Patrick C.N. Rensen, Peter Carmeliet, Albert K. Groen, Judith C. Sluimer

Article2011

Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche

Matilda Rehn, André Olsson, Kristian Reckzeh, Eva Diffner, Peter Carmeliet, Göran Landberg, Jörg Cammenga

Article2012

Cell sheet engineering for reproducing the bone marrow hematopoietic stem cell niche

Rogério P. Pirraco, Alexandra P. Marques, Rui L Reis

Article2013

HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia

Kiave-Yune HoWangYin, Céline Loinard, Wineke Bakker, Coralie L. Guérin, José Vilar, Clément d’Audigier, Laëtitia Mauge, Patrick Bruneval, Joseph Emmerich, Bernard Lévy, Jacques Pouysségur, David M. Smadja, Jean‐Sébastien Silvestre